NDC product
Allergy and Congestion Relief
NDC 0113-2007 · L. Perrigo Company
Key facts
| Product NDC | 0113-2007 |
|---|---|
| Proprietary name | Allergy and Congestion Relief |
| Nonproprietary name | loratadine, Pseudoephedrine sulfate |
| Substances | LORATADINE, PSEUDOEPHEDRINE SULFATE |
| Dosage form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | L. Perrigo Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA076050 |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
| Marketing start | Apr 12, 2018 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: